Is hypertension a leading cause of heart failure in Chinese?

M Gary Nicholls1, A Mark Richards

  • 1Department of Medicine, Christchurch Hospital, Christchurch, New Zealand. gary.nicholls@chmeds.ac.nz

Insights

Hypertension is the primary risk factor for heart failure in Chinese populations, though diabetes prevalence is rising. Further research is needed to confirm findings in diverse ethnic groups.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Risk factors for heart failure (HF) are not fully understood, with most data from Caucasian populations.
  • Hypertension and coronary artery disease are dominant HF risk factors in Caucasians.
  • Risk factor profiles for heart failure may differ across racial and ethnic groups.

Purpose of the Study:

  • To review the literature on the aetiology of heart failure specifically in the Chinese population.
  • To identify the predominant risk factors contributing to heart failure development in Chinese individuals.

Main Methods:

  • Literature review of studies on heart failure aetiology in Chinese populations.
  • Analysis of data from Hong Kong studies conducted in the 1990s.
  • Examination of the prevalence of diastolic heart failure and associated risk factors.

Main Results:

  • No long-term prospective studies definitively identify heart failure risk factors in Chinese.
  • Hypertension, ischaemic heart disease, and diabetes mellitus are overlapping risk factors.
  • Diastolic heart failure has a high prevalence (66%) in the studied Chinese population.
  • Antihypertensive drug treatment may offer protection against heart failure, but trial data are limited.

Conclusions:

  • Hypertension appears to be the most significant identifiable risk factor for heart failure in Chinese individuals.
  • The increasing prevalence of diabetes mellitus may alter future heart failure risk profiles in this population.
  • Further prospective studies are required to definitively establish heart failure aetiology in diverse ethnic groups.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...